Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-97-001439
Filing Date
1997-02-14
Accepted
1997-02-14 00:00:00
Documents
4
Period of Report
1996-12-31
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 ONCOGENE FORM 10-Q: PERIOD END 12/31/96 10-Q 32737
2 RESEARCH AND LICENSE AGREEMENT EX-10.1 69249
3 DEVELOPEMENT AND COMMERCIALIZATION AGREEMENT EX-10.2 85336
4 FINANCIAL DATA SCHEDULE EX-27 2150
  Complete submission text file 0000950123-97-001439.txt   191276
Mailing Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553-3649
Business Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553 5162220023
ONCOGENE SCIENCE INC (Filer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-15190 | Film No.: 97536056
SIC: 2835 In Vitro & In Vivo Diagnostic Substances